Ecuador Medical Device Registration 2026: Registration Holder Change and Market Exit Procedures

Updated: 2026-11-12 · GRZAN Regulatory Team · Verification date 2026-10-20

1. Key takeaways

There are two statutory routes out of an existing registration holder arrangement: Article 42 provides that a change of product owner, registration certificate holder, manufacturer or principal manufacturer is among the changes that do not require re-application for the registration certificate and are processed through the change procedure (modificación); and Articles 46 to 47 provide that voluntary cancellation requires submission of the holder’s appointment document together with a market withdrawal strategy, and that no fee is charged for the cancellation procedure.

2. Legal basis

RegulationReference numberPublication dateArticle provisions
Substitute Technical Sanitary Regulation for the Registration, Control and Surveillance of Medical Devices for Human UseResolución ARCSA-DE-2026-003-DASPSigned 2026-04-28Article 42 (cases not requiring re-registration)
Same regulationSameSameArticle 43 (change procedure), Articles 44 to 45 (no commercialization before approval of the change)
Same regulationSameSameArticle 46 (voluntary cancellation documents), Article 47 (voluntary cancellation procedure)

Cases listed in Article 42 that do not require re-registration (in excerpt): (a) change of trade name; (b) change of the product owner, the registration certificate holder, the manufacturer or the principal manufacturer; (c) change of the name or business name of any of the foregoing parties; (d) change of address of the manufacturer, product owner, holder or conditioning establishment; (e) model changes that do not affect the risk level, the intended use or the approved characteristics; (f) changes in the chemical composition of raw materials that do not affect the risk level; (g) changes in the nature of the container or packaging materials that do not alter the sterile status of the product; and (h) changes, additions or exclusions in the commercial presentation of the product.

3. Expert insights

Insight 1: Article 42(b) is the statutory mitigation mechanism for channel risk. Replacing the registration holder, the product owner or the manufacturer does not require a new registration application and is handled through the change procedure. This substantially lowers the institutional cost of switching channel partners, provided that the cooperation of the original holder can be obtained. The saving is not only monetary: a fresh registration would restart classification, dossier review and timeline risk, whereas the change procedure amends an existing certificate.

Insight 2: Articles 44 and 45 impose prohibitions before approval of a change, and the rules differ for domestic and imported products.

  • Article 44 (domestic products): the holder may not manufacture or commercialize devices incorporating any of the changes listed in Article 42 unless the change has been previously approved by ARCSA;
  • Article 45 (imported products): the holder may not import or commercialize devices incorporating any of the changes listed in Article 42, where the change affects the labeling or the instructions for use, unless prior approval has been obtained from ARCSA.

The difference is that the prohibition for imported products is confined to changes affecting the labeling or the instructions for use.

Insight 3: The change procedure is also subject to the single deficiency response rule. Article 43(4) provides that where the review is not passed, the file is returned to the holder for correction with a period of 5 days, granted only once; if the deadline is missed or the correction is insufficient, the status is recorded as not approved and the procedure is definitively closed. A failed change attempt therefore consumes the procedure entirely and must be restarted from the beginning.

Insight 4: Voluntary cancellation has three official requirements, and a market withdrawal strategy is mandatory. Under Article 46 the file must contain: (a) the cancellation application, in the format established by ARCSA, stating the registration certificate number to be cancelled and the grounds; (b) the appointment document of the registration holder; and (c) a market withdrawal strategy, in accordance with the instructions issued by ARCSA. Article 47 provides that the cancellation application is not subject to any fee.

Insight 5: The review period for voluntary cancellation is 60 days, and cancellation has a consolidated effect. Under Article 47(2) and (3), ARCSA reviews within 60 days; where the opinion is favorable, the corresponding registration certificate is cancelled together with all pending applications associated with that certificate. This means a cancellation request extinguishes any change or renewal applications that are still under review at the time.

4. Practical recommendations

  1. Include a change cooperation obligation in the agreement with the registration holder: define the period after termination within which the holder must sign change declarations, and the liability for breach.
  2. Record the ownership of the registration certificate in the contract, making the separation between the nominal holder and the underlying commercial rights explicit.
  3. Finalize labeling and instructions for use before submitting a change application, to avoid triggering the import prohibition of Article 45.
  4. Close out pending applications before requesting voluntary cancellation, to avoid the consolidated cancellation loss described in Article 47(3).
  5. Prepare the market withdrawal strategy in advance, covering inventory disposition, continuation of vigilance obligations and a notification plan for end users, so that the cancellation file can be submitted complete on the first attempt.

5. Verification checklist

  • □ The agreement sets out the holder’s change cooperation obligation and liability for breach
  • □ Ownership of the registration certificate has been clarified in the contract
  • □ It has been confirmed whether the change affects labeling and instructions for use (Article 45 test)
  • □ The voluntary cancellation file includes the holder appointment document and the market withdrawal strategy
  • □ All pending applications have been resolved or withdrawn before cancellation
  • □ It has been confirmed that voluntary cancellation carries no fee

Regulatory information verified as of October 29, 2026

GRZAN service note

GRZAN provides regulatory support in this country for medical device manufacturers, importers and authorized representatives, covering registration pathway planning, holder change and market exit strategy design, change procedure management, official fee and timeline estimation, technical dossier preparation, and post-market compliance management. Manufacturers and importers planning a holder transition or a structured exit from the Ecuador market may contact GRZAN at info@grzanglobal.com for a tailored solution.

Disclaimer

Prepared by GRZAN from publicly available regulation. It is provided for general information only and does not constitute legal advice. Legislation and official fees are subject to change by the competent authority.

About GRZAN

GRZAN (Global Regulatory Zone Access Navigator) — the global market-access navigator for medical devices and IVDs.

GRZAN is a specialist consultancy for medical device and IVD market access, providing end-to-end regulatory solutions across the product lifecycle and making international market entry simpler and faster.

Key figures. More than 25 wholly owned subsidiaries worldwide covering 50+ countries and regions; chosen by 100+ listed and leading Chinese device manufacturers, with 4,000+ successful cases; 12+ years in the sector and 200+ regulatory training sessions and seminars delivered.

What we do. Global market access: multi-country registration programmes, technical documentation, regulatory advice. Clinical evidence: clinical evaluation reports (CER), usability studies, overseas clinical investigations. Quality systems: ISO 13485, MDSAP, FDA QMSR and BGMP implementation and audit readiness. Authorised representative and licence-holder services across Southeast Asia, Latin America, the Middle East, Africa, Europe and North America.

Why GRZAN. A real operating entity, with the certificate held by the manufacturer: our direct overseas subsidiaries act as the compliant local holder, so the regulatory relationship stays clear and you keep control rather than being tied to a distributor. Direct access to the team: no time-zone gap, no language barrier, no cultural gap. Review points anticipated: we know what FDA 510(k), EU MDR, Southeast Asian, Latin American and Middle Eastern reviewers look for, which shortens timelines and reduces deficiency letters. Pathway planning: pre-decision analysis and risk assessment before you commit.

Every engagement rests on three commitments: efficiency through pre-submission review, certainty through a clear pathway, and stability through a licence-holder that stays in place.

Take your devices global with GRZAN

We work with manufacturers worldwide to open new markets with a clear regulatory pathway.

Contact us
WhatsApp
QR Code
WhatsApp QR Code
Scan to chat on WhatsApp
Phone
Call
Office Mon-Fri 9:00-18:00
0755-88659477
Mobile 24/7 Service
+86 15816864648
Email
Mail